Hello! Was this newsletter forwarded to you? Sign up here.
The COVID-19 Insights & Analytics newsletter is designed to provide you with a summary to quantify national trends that may help in COVID-19 response planning. The included data, analytics and dashboards are generated utilizing BD HealthSight™ Infection Advisor Analytics and are derived from electronic patient data from 338 participating U.S. hospitals initiated on March 1, 2020 through November 23, 2020 unless otherwise indicated.
Previous respiratory viral epidemics have been associated with increased rates of co-infections (“super infections”) with other additional viral, bacterial or fungal infections1. We evaluated antimicrobial use and culture source for US hospitalized COVID-19 tested patients from 246 hospitals between March 1 – May 31, 2020.